Company intelligence / Profile preview

Jawale Institute of Pediatric Surgery

Jalgaon, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

The institute has conducted several clinical studies on autologous stem cell transplantation, particularly for Type 1 diabetes and Cerebral Palsy. Results for Type 1 diabetes (n=25) showed significant weight gain, reduced insulin requirements, increased C-peptide levels, and decreased HbA1c levels. They also manufacture over 100 low-cost medical devices used worldwide.

Therapeutic areas: NephrologyEndocrinologyMen's HealthNeurology
Modalities: Stem cell therapyGene therapyCRISPR-based therapyDeviceSurgical procedure
Industry: Biotech

Partnerships

Thermo Fisher Scientific (Gene therapy facility setup)

Beyond the preview

Go deeper on Jawale Institute of Pediatric Surgery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jawale Institute of Pediatric Surgery.

Explore the full profile